Congenital heart disease

Percutaneous Pulmonary Flow Restriction in Infants With Congenital Heart Disease

JACC AdvPublished Single-centre case series

Authors' conclusion

Percutaneous PBF restriction appears to be safe and a less invasive option to delay surgical intervention in a select population to allow for somatic growth and gestational maturation.

Study context

Population
Neonates with congenital heart disease (CHD) resulting in left-sided obstruction, selected for low birth weight or prematurity
Participants
7 neonates
Outcome
Restriction of PBF

Main finding

As reported in the abstract

  • All patients had restricted pulmonary blood flow (PBF); mean oxygen saturation decreased from 95% to 84%
  • All patients proceeded to full surgical intervention

Observational data: associations, not effects.

Further findings

Presurgical catheterization hemodynamics (5 patients)

Mean pulmonary vascular resistance
1.52 WU × m²
Mean transpulmonary gradient
5.9 mm Hg
Adequate limitation of PBF
5 patients

Safety

Pulmonary artery band placement due to over-circulation · 5 days after the procedure

Patients requiring PA band
One patient

Device embolization or need for pulmonary arterioplasty

All patients proceeded to full surgical intervention without device embolization or need for pulmonary arterioplasty

Original publication

Percutaneous Pulmonary Flow Restriction in Infants With Congenital Heart Disease. JACC Adv. Published 7 June 2024. doi:10.1016/j.jacadv.2024.101031

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.